Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
With its acquisition of IRISYS, Recro has transformed itself into a full-service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-...
read more
Wednesday, January 19, 2022
Recro Pharma, Inc. announced the appointment of Eduardo Uribe as the company’s head of quality for Recro San Diego. Mr. Uribe has more than 30 years of experience developing, implementing and managing quality systems within the biotechnology and ...
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more
Monday, November 05, 2018
Recro Gainesville has added a 24,000-square-foot facility near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant.
read more
Thursday, February 24, 2022
Recro Pharma reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings. All construction and equipment installation related to this service expansion has been completed at the company’s San Diego...
read more
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ...
read more
Wednesday, October 14, 2020
RedHill announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib.
read more
Monday, February 01, 2021
RedHill Biopharma announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib.
read more
Friday, September 04, 2020
RedHill announced the selection of opaganib1 for severe COVID-19 pneumonia.
read more
RedHill Biopharma has entered into a binding term sheet with Cosmo Pharmaceuticals for an exclusive licensing and manufacturing agreement for multiple products.
read more
ReForm Biologics announced a collaboration with Astellas Pharma to reduce the viscosity of an Astellas clinical-stage biological pipeline program.
read more
Monday, February 10, 2020
ReForm Biologics and MilliporeSigma announced a global license agreement and collaboration to commercialize proprietary ReForm excipients used in biotherapeutic formulations.
read more
Thursday, August 20, 2020
Regeneron and Roche are working together to develop, manufacture and distribute REGN-COV2, Regeneron's investigational anti-viral antibody cocktail.
read more
ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products for advanced therapies, and Exothera, a full-service Contract Development and Manufacturing...
read more
Wednesday, December 30, 2020
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras announce the signing of an exclusive contract for human relaxin-2.
read more